Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.
暂无分享,去创建一个
Katarzyna J Macura | John Kurhanewicz | Jeffrey D Blume | Akira Kawashima | Mark Rosen | Jeffrey C Weinreb | Jean B. Cormack | J. Kurhanewicz | C. Tempany-Afdhal | K. Macura | M. Rosen | A. Kawashima | J. Weinreb | T. Wheeler | J. Blume | F. Coakley | Fergus V Coakley | Christopher K Sotto | Haesun Cho | S. Gerst | Thomas M Wheeler | Scott R Gerst | Clare M Tempany-Afdhal | Jean B Cormack | Haesun Cho
[1] N A Obuchowski,et al. Sample size calculations in studies of test accuracy , 1998, Statistical methods in medical research.
[2] Yuri Kitamura,et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. , 2006, AJR. American journal of roentgenology.
[3] T. Stamey,et al. Biological determinants of cancer progression in men with prostate cancer. , 1999, JAMA.
[4] J Alfred Witjes,et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. , 2005, Radiology.
[5] J. Pauly,et al. Dualband spectral‐spatial RF pulses for prostate MR spectroscopic imaging , 2001, Magnetic resonance in medicine.
[6] P. Littrup,et al. Workgroup #2: Screening and detection reference range/clinical issues of PSA , 1993, Cancer.
[7] C. Öbek,et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. , 1999, The Journal of urology.
[8] G. P. Krestin,et al. Optimization of prostate carcinoma staging: Comparison of imaging and clinical methods , 1995 .
[9] P. Carroll,et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. , 2004, Radiology.
[10] J. Kurhanewicz,et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.
[11] A W Partin,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.
[12] Benjamin M Yeh,et al. Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. , 2008, Radiology.
[13] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[14] T. Wheeler,et al. Fresh tissue harvest for research from prostatectomy specimens , 1994, The Prostate.
[15] Jean-Jacques Patard,et al. Value of Ultrasound-Guided Systematic Sextant Biopsies in Prostate Tumor Mapping , 1999, European Urology.
[16] N A Obuchowski,et al. Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. , 1997, Statistics in medicine.
[17] Silvia D. Chang,et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.
[18] C. Gatsonis,et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. , 1990, The New England journal of medicine.
[19] Ruth Etzioni,et al. Estimating Health Care Costs Related to Cancer Treatment From SEER-Medicare Data , 2002, Medical care.
[20] N A Obuchowski,et al. Computing Sample Size for Receiver Operating Characteristic Studies , 1994, Investigative radiology.
[21] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[22] C W Piccoli,et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. , 1994, Radiology.
[23] M. Kattan,et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. , 2003, Radiology.
[24] P. Carroll,et al. Focal therapy for prostate cancer 1996: maximizing outcome. , 1997, Urology.
[25] N A Obuchowski,et al. Multireader, multimodality receiver operating characteristic curve studies: hypothesis testing and sample size estimation using an analysis of variance approach with dependent observations. , 1995, Academic radiology.
[26] Evis Sala,et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.
[27] D. Mitchell,et al. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. , 1995, Radiology.
[28] J A Smith,et al. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. , 1997, The Journal of urology.
[29] J. Kurhanewicz,et al. Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. , 2007, Radiology.
[30] J Lipscomb,et al. The burden of illness of cancer: economic cost and quality of life. , 2001, Annual review of public health.
[31] Dennis W J Klomp,et al. Initial Experience of 3 Tesla Endorectal Coil Magnetic Resonance Imaging and 1H-Spectroscopic Imaging of the Prostate , 2004, Investigative radiology.
[32] P. Carroll,et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. , 1996, Radiology.
[33] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[34] D. Grignon,et al. Prostate cancer: indicators of aggressiveness. , 1997, European urology.
[35] C P Langlotz,et al. Prostate cancer: what is the future role for imaging? , 2001, AJR. American journal of roentgenology.
[36] A. D'Amico,et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. , 2000, The Journal of urology.
[37] Alan W Partin,et al. Radical prostatectomy for clinical stage T3a disease , 2007, Cancer.
[38] R Alagappan,et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. , 1997, Radiology.
[39] M. Cooperberg,et al. National practice patterns and time trends in androgen ablation for localized prostate cancer. , 2003, Journal of the National Cancer Institute.
[40] A W Partin,et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.
[41] N A Obuchowski,et al. Nonparametric analysis of clustered ROC curve data. , 1997, Biometrics.
[42] J Kurhanewicz,et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.
[43] J. Kurhanewicz,et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer , 2000, Magnetic resonance in medicine.
[44] Silvia D. Chang,et al. Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.
[45] P. Carroll,et al. Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. , 2006, Radiology.